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Abstract
AIM: The aim of this study was to evaluate the prevalence of Staphylococcus aureus and methicillin-resistant 
S. aureus (MRSA) in clinical specimens hospitalized to “Mother Theresa” Hospital Center for 2 years.
METHODS: We isolated and identified S. aureus on 356 clinical specimens using standard tests. Furthermore, for 
further accurate microbial identification, we have to use the VITEK® 2 system. The samples were tested to detect the 
presence of MRSA by a slide latex agglutination kit for the rapid detection of PBP2.
RESULTS: The overall prevalence of S. aureus in patients was 34.2%. The prevalence of MRSA was 20.5% of cases. 
Of the MRSA isolates identified in this study, 28% were susceptible to antibiotics, 24% demonstrated intermediate 
resistance, and 48% were multi-drug resistant with resistance to nineteen antibiotics involved in the examination. In 
addition, seven of the 25 MRSA cases showed 100% resistance to norfloxacin, imipenem, meropenem, levofloxacin, etc.
CONCLUSIONS: The rate of S. aureus in hospitalized patients on this study was 34.2% and the MRSA 20.5%. 
These results indicated that this type of infection is a significant concern for health services and patients included. 
A screening of all hospitalized cases can lead to reduce the incidence of this infection in the hospital environment.
Introduction
Staphylococcus aureus, a member of the 
family Micrococcaceae, is a Gram-positive coccus 
whose cells tend to occur either singly or if dividing cells 
do not separate, form pairs, tetrads, and distinctive 
irregular “grape-like” structures [1], [2]. S. aureus is a 
common human opportunistic pathogen often carried 
asymptomatically on the human body. However, in 
some circumstances, this bacteria can cause more 
serious infections in a wide range which affecting 
the superficial skin and soft tissue [3], [4], as well as 
invasive infections including pneumonia, bloodstream 
infections, bone, and joint infections [2], [4]. Infections 
caused by S. aureus, above all, by antibiotic-resistant 
strains, have reached epidemic proportions globally [5]. 
Methicillin-resistant S. aureus (MRSA) was first 
reported in 1961 and has since become a major 
nosocomial pathogen worldwide [2], [5], [6], [7], [8]. 
MRSA includes those strains that have acquired 
a gene giving them resistance to methicillin and 
essentially all other beta-lactam antibiotics [9]. Since 
that time, MRSA has emerged as a significant problem 
worldwide [10], [11], [12], [13], [14], and the term has 
evolved to include resistance to additional ß-lactam 
antimicrobials. At present, the term MRSA is often 
used to describe multi-drug resistant S. aureus [15]. 
In nowadays, the incidence of MRSA is growing and 
unfortunately efforts to develop new, more effective 
antibiotics are dwindling. The continued emergence of 
resistant strains of bacteria such as MRSA demands 
an urgent revival of the search for new antibiotics [16]. 
MRSA in a different group of patients (especially in 
immunocompromised and operated patients) causes 
different clinical syndromes and different antimicrobial 
susceptibility patterns. For this reason, the aim of this 
study was to evaluate the prevalence of S. aureus 
MRSA cases who were hospitalized patients at the 
“Mother Theresa,” Hospital Center, during the period 
January 2014–December 2015.
Materials and Methods
This study was carried out from January 2014 
to December 31, 2015, at “Mother Theresa” Hospital, 
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a tertiary care university hospital in Tirana, Albania. 
UHC “Mother Theresa” is the only reference center in 
Albania for acute and critical patients. About 356 clinical 
specimens were collected by hospitalized patients aged 
18 years or older.
Patients enrolled in this study were hospitalized 
in different wards such as infection diseases, cardiology, 
dialyses, surgery, dermatology, nephrology, cardiology, 
neurology, intensive care, etc.
A questionnaire was used to collect socioeconomic 
and demographic data from medical personalized files of 
each patient. The demographic data include age, sex, 
school education, residence (urban/rural), marital status, 
and number of children. In the medical records, we have 
viewed information about regarding the reason why he or 
she was been hospitalized, if they were used antibiotic 
during the hospitalized, there have chronic diseases (such 
as hypertension, cardiac diseases, diabetes mellitus 
(type 2 and 1), and liver and kidney dysfunction). Wound, 
abscess, pus/exudates, skin and soft tissue swab, blood, 
urine, sputum, throat swab, and indwelling medical device 
samples were collected from suspected patients. All 
specimens were sent to the microbiology laboratory within 
1 h. Immediately, the samples were streaked on to Sheep 
Blood agar plate and other media for Gram-negative 
bacteria and incubated in 37°C for 24 h. We isolated and 
identified S. aureus on the basis of colony morphology 
and also we used catalase test, coagulase test, mannitol 
fermentation on mannitol salt agar, production of 
deoxyribonuclease (DNase) on DNase agar, Staphyloslide 
Latex Test, and CHROMagar Orientation.
Furthermore, for further accurate microbial 
identification, we have to use the VITEK® 2 system. 
For susceptibility tests, we use both automated 
Microbiology System (VITEK® 2 system) and Kirby–
Bauer Disk Diffusion Susceptibility Test. The main 
antibiotics used for susceptibility tests were cefoxitin, 
moxifloxacin, cefixime, norfloxacin, imipenem, 
doxycycline, meropenem, vancomycin, rifampicin, 
clindamycin, amoxicillin, levofloxacin, ceftriaxone, 
gentamycin, nitrofurantoin, cefaclor, ceftazidime, 
cefotaxime, cefuroxime, and amikacin.
The samples were tested to detect the 
presence of MRSA (S. aureus methicillin resistance) by 
a slide latex agglutination kit for the rapid detection of 
PBP2 (the enzyme encoded by mecA), the cefoxitin disk 
screen test and sometime with CHROMagar™ MRSA.
For statistical analyses, all the data were 
expressed in frequencies and percentages. Chi-square 
test and Fisher’s exact test were used to determine 
relationships between categorical variables. In the 
univariate analyses of risk factors, age, number of 
household, and income were categorized. p < 0.05 
indicated a statistically significant difference in all tests.
All data collected from the medical files of each 
patient were analyzed by SPSS version 20.0 (SPSS 
Inc., Chicago, IL, USA).
Results
Overall, 356 samples tested for the presence 
of S. aureus, only 34.2% (122/356) of them, resulted 
positive with S. aureus. The prevalence of MRSA was 
20.5% (25/122) cases (Figures 1 and 2).
Figure 1: Prevalence of Staphylococcus aureus
In Table 1, we have presented the 
demographic characteristics data of patients 
admitted to the “Mother Theresa” Hospital Centre. 
Male (59.8%) was the most predominant sex in 
this study compared to female (40.2%) without a 
significance level between them. The min age was 
18 and the max 83 years old and the average was 
54.6 ± 17.3.
Figure 2: Prevalence of methicillin-resistant Staphylococcus aureus
Patients that living in rural area were more 
predominant compared to them that living in an urban 
area 64.9% and 35.1%, respectively. A strong association 
has found for residence area and presence of S. aureus. 
Based on age groups, patients more than 66-year-old 
presented the highest number of patients (32.9%) and 
the prevalence of S. aureus in this group was 31.1%. 
We have not found any association between age 
groups and the presence of S. aureus. For demographic 
characteristics of patients such as marital status, level 
of school education, and social level, married patients 
presented 75.3% of total cases but was not been found 
any association between the presence of S. aureus and 
marital status. On the other hand, we have found a strong 
association between the presence of this infection and 
the school education of patients as well as their social 
level.
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Discussion
Nowadays, the prevalence of S. aureus and 
methicillin resistance of S. aureus (MRSA) is very 
common in most of the countries. The prevalence of 
MRSA varies from one geographic region to another 
and between different institutions in a given area [17] 
and the prevalence of infections and outbreaks due to of 
Table 1: Demographic characteristics of patients admitted to “Mother Theresa” Hospital Center
Demographic data Frequency Percentage Prevalence of S. aureus p value Prevalence of MRSA
Sex >0.05
Female 143 40.2 37.7 36
Male 213 59.8 62.3 64
Residence area =0.003
Urban 125 35.1 33.6 44
Rural 231 64.9 66.4 56
Age groups (years) >0.05
18–25 32 9 5.7 4
26–35 28 7.8 7.4 4
36–45 40 11.2 12.3 8
46–55 73 20.5 20.5 20
56–65 66 18.5 23 36
>66+ 117 32.9 31.1 28
Marital status >0.05
Married 268 75.3 69 52
Single/separated 37 10.4 10.5 20
Widowed 51 14.3 20.5 28
School education (level) <0.0001
Elementary 4 1.1 3.3 4
8-years 132 37.1 41.8 40
High school 120 33.7 33.6 32
University 100 28.1 21.3 24
Social level =0.004
School/Student 32 9 6.5 8
Invalid 18 5 7.4 12
Without work 80 22.5 26.2 28
Employed 130 36.5 36.9 28
Retiree 96 27 23 24
MRSA: Methicillin-resistant S. aureus, S. aureus: Staphylococcus aureus.
Table 2 presents the positivity of S. aureus 
and MRSA divided by the wards were the samples of 
patients are collected.
Table 2: Positivity of S. aureus and MRSA based toward 
collected samples
Wards Total number S. aureus MRSA
Positive Negative MSSA MRSA
Cardiology 59 16 43 11 5
Dialysis 19 7 12 2 5
Infection diseases 53 20 33 17 3
Nephrology 41 14 27 11 3
Neurology 12 7 5 10 2
Surgical 68 22 46 19 3
Dermatology 104 36 68 32 4
Total 356 122 234 97 25
MRSA: Methicillin-resistant S. aureus, S. aureus: Staphylococcus aureus.
In Figure 3, we have presented the distribution 
of S. aureus and MRSA positive cases.
Figure 3: Distribution of positive cases with Staphylococcus aureus 
and methicillin-resistant S. aureus+
In Table 3, we have presented the antibiotics 
admitted to examination to see the sensitivity and 
resistant of MRSA cases.
Table 4 presents the prevalence of infection 
with S. aureus based to the source of clinical 
specimens.
Table 3: Antibiotics used for MRSA
Antibiotics Type of S. aureus MRSA
Sensitive (%) Resistant (%) Intermediate (%)
Cefoxitin 10 90 0
Moxifloxacin 88 5 7
Cefixime 0 85 15
Norfloxacin 0 100 0
Imipenem 0 100 0
Doxycycline 50 29 21
Meropenem 0 100 0
Vancomycin 12 30 58
Rifampicin 77 13 10
Clindamycin 29 58 13
Amoxicillin 59 25 36
Levofloxacin 0 100 0
Ceftriaxone 0 90% 10
Gentamycin 0 75 25
Nitrofurantoin 78 0 12
Cefaclor 0 100 0
Ceftazidime 0 100 0
Cefotaxime 0 100 0
Cefuroxime 5 95 0
Amikacin 88 2 10
MRSA: Methicillin-resistant S. aureus, S. aureus: Staphylococcus aureus.
Table 4: Prevalence of infection with S. aureus based to source 
of clinical specimens
Cases collected from Frequency (n) Percentage (%) Positive cases (n)
Urine infections 75 21.0 21
Skin and soft-tissue infections 96 27 32
Vaginal and urethral swab 47 13.2 15
From nasal, sputum and ear swab 
cases
58 16.3 18
Bloodstream, indwelling medical 
devices, and catheter-associated 
infections
80 22.5 36
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S. aureus and MRSA has continued to increase in many 
of countries [17], [18], [19], [20]. Fact is that S. aureus 
and MRSA present different prevalence around the 
world and also around European countries [21]. The aim 
of this study was to evaluate the prevalence of S. aureus 
and MRSA in clinical specimens hospitalized to “Mother 
Theresa” University Hospital Center. This study is not the 
first prevalence survey on S. aureus infection and MRSA 
in patients admitted at “Mother Theresa” University 
Hospital Centre [22], [23], [24]. Overall, 356 samples 
tested for the presence of S. aureus, the prevalence of 
this infection among hospitalized patients resulted to be 
34.2% (122/356). The prevalence of MRSA was 20.5% 
(25/122) of cases. In the previous study conducted in 
Albania, the MRSA in admitted patients was 14.2% 
MRSA nasal carriers in 2016, a study survey by Falzon 
et al. [22], 24% methicillin-resistant measured with 
MRSA-Screen in a study 2017 by Dako et al. [23]. 
Another study in 2003 by Faria et al. conducted in 
Mother Theresa Hospital Centre, the prevalence of S. 
aureus resulted 18.2% in admitted patients [24].
Our finding of MRSA prevalence (20.5%) 
is almost the same with another study conducted in 
Greece, which had a prevalence of 20% of MRSA in 
screened hospitalized patients [25]. However, we have 
a high prevalence if compare with the finding in Croatia 
that reports a MRSA 5.2% [26] and Serbia 11.8% [27].
Regarding the demographic characteristics data 
of patients admitted to the “Mother Theresa” Hospital 
Centre, presented in Table 1, the min age was 18 and 
the max 83 years old and the average was 54. 6 ± 17.3.
Male (59.8%) was the most predominant sex in 
this study compared to female (40.2%). The prevalence 
of S. aureus infection and MRSA divided by gender was 
37.7% (S. aureus) with 36% (MRSA) for female and for 
male 62.3% (S. aureus) with 64% (MRSA); however, 
we did not find a significant association between 
gender and infection. If we compare the living areas of 
our patients, can be mention that more than half living 
in rural areas (64.9%) and the others in urban areas 
(35.1%). The prevalence of S. aureus in patients that 
lived in the rural area was distinctly the highest to those 
living in the urban area (66.4% and 33.6%, respectively). 
A strong significant association has found for residence 
area and presence of S. aureus for p = 0.003.
Faria et al., in their study, according to the 
means of logistic regression, proved that the age 
>40 years is an independent risk factor for S. aureus 
infection [24]. In our study, patients, more than 66 years 
old, presented the highest number of patients 32.9%, 
but we have not found any association between age 
groups and presence of S. aureus (p > 0.05). Married 
patients presented 75.3% of total cases, and in this 
demographic characteristic, we did not found any 
significant association between this infection and 
marital status of patients (p > 0.05).
However, on the other hand, in patients 
admitted to “Mother Theresa” Hospital Centre, we have 
found a strong association between the presence of 
S. aureus and school education (p < 0.0001) as well as 
the social level (for p = 0.004).
The prevalence of S. aureus on each wards 
resulted to be; 27.1% (16/59) for cardiology, 36.8% 
(7/19) dialysis, 37.3% (20/53) infection diseases, 34.14% 
(14/41) nephrology, 58.3% (7/12) neurology, 32.35% 
(22/68) surgical, and 34.6% (36/104) dermatology. The 
prevalence of MRSA was higher in cardiology wards (20%) 
than in dialysis (20%) and dermatology wards (16%). We 
did not found an association forward sample collection 
and presence of S. aureus, p value result > 0.05.
MRSA is an increasingly important clinical 
problem since MRSA is often multidrug-resistant and 
therapeutic options are limited. In this study, we have 
identified 25 MRSA isolates cases, in which 7 (28%) 
were susceptible to antibiotics, 6 (24%) demonstrated 
intermediate resistance and 12 (48%) were multi-
drug resistant with resistance to nineteen antibiotics 
involved in the examination. In addition, seven of the 25 
MRSA cases showed 100% resistance to norfloxacin, 
imipenem, meropenem, levofloxacin, cefaclor, 
ceftazidime, and cefotaxime.
Samples were taken out from the skin and soft-
tissue infection, urine infection and from nasal, sputum, 
and ear swab and also from bloodstream, indwelling 
medical devices, and catheter-associated infections. 
Of all 122 cases isolated with S. aureus, 21 (17.2%) 
were from urine infections; 32 (26.2%) from skin and 
soft-tissue infections cases; 15 (12.3%) from vaginal 
and urethral swab; 18 (14.8%) from nasal and ear swab 
cases; and 36 (29.5%) from bloodstream and catheter-
associated infections.
Conclusions
The rate of S. aureus in hospitalized patients 
on this study was 34% and the MRSA 20.5%. These 
results indicated that this type of infection is a significant 
concern for health services and patients included in 
the study. The highest percentage of S. aureus found 
in surgical and nonsurgical wound suggest that further 
investigation should be implemented. A screening of all 
hospitalized cases can lead to reduce the incidence of 
this infection in the hospital environment and also to 
control the risk factors.
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